Image Source: TechCrunch
Hims & Hers Health, the leading US-based telehealth platform, has announced a major step in its international expansion by acquiring UK-based digital health startup Zava.
This strategic deal, expected to close in the second half of 2025, will significantly boost Hims & Hers’ presence across the United Kingdom and officially launch its services in Germany, France, and Ireland, with more European markets anticipated soon.
Key Highlights
Expansion into Europe: The acquisition will give Hims & Hers direct access to Zava’s robust operations in the UK, Germany, France, and Ireland, expanding its active customer base by roughly 50%, or about 1.3 million new users.
All-Cash Deal: The transaction will be funded entirely by cash from Hims & Hers’ balance sheet. Financial terms remain undisclosed but will be detailed in the company’s next earnings report.
Broader Service Offerings: Hims & Hers plans to introduce personalized care in dermatology, mental health, sexual health, and weight loss, with local language support for patients in new markets.
Strategic Timing: The move comes as Hims & Hers adapts to recent US regulatory changes affecting telehealth and weight-loss drug offerings, and follows its 2021 acquisition of Honest Health in London.
Zava’s Track Record: Zava, backed by HPE Growth, delivered nearly 2.3 million consultations in 2024 and is rated ‘outstanding’ for leadership by the UK Care Quality Commission. Its portfolio covers weight management, women’s and men’s health, sexual health, general medicine, and skin & hair care.
Leadership Perspective: Hims & Hers CEO Andrew Dudum called the acquisition a “pivotal moment” for accelerating European expansion, while Zava CEO David Meinertz emphasized the potential to ease pressure on strained European healthcare systems.
Future Growth: Hims & Hers will establish its branded presence in these markets and expects the integration to positively impact its financial performance by 2026.
“Whether in rural towns, vibrant cities, or remote communities across Europe, people battling widespread, often silent chronic conditions like obesity, depression, and more will have access to the personalized, high-quality care they deserve,” said Andrew Dudum, CEO of Hims & Hers.
Source: CNBC, Reuters, Business Wire, Bloomberg, Global Banking & Finance Review, Investing.com.
Advertisement
Advertisement